OpenLB
Open Library of Bioscience
Advanced Search
One health (Amsterdam, Netherlands)
Jun, 2022;14 100390.

Multidrug resistance from a one health perspective in Ethiopia: A systematic review and meta-analysis of literature (2015-2020).

Mebrahtu Tweldemedhin, Saravanan Muthupandian, Tsega Kahsay Gebremeskel, Kibrti Mehari, Getahun Kahsay Abay, Teklay Gebrecherkos Teklu, Ranjithkumar Dhandapani, Ragul Paramasivam, Tsehaye Asmelash
Author Information
  1. Mebrahtu Tweldemedhin: Department of Medical Microbiology and Immunology, College of Health Sciences, Mekelle University, Ethiopia.
  2. Saravanan Muthupandian: Department of Medical Microbiology and Immunology, College of Health Sciences, Mekelle University, Ethiopia.
  3. Tsega Kahsay Gebremeskel: Department of Medical Microbiology and Immunology, College of Health Sciences, Mekelle University, Ethiopia.
  4. Kibrti Mehari: Department of Medical Microbiology and Immunology, College of Health Sciences, Mekelle University, Ethiopia.
  5. Getahun Kahsay Abay: Department of Medical Microbiology and Immunology, College of Health Sciences, Mekelle University, Ethiopia.
  6. Teklay Gebrecherkos Teklu: Department of Medical Microbiology and Immunology, College of Health Sciences, Mekelle University, Ethiopia.
  7. Ranjithkumar Dhandapani: Chimertech Private Limited, Chennai, India.
  8. Ragul Paramasivam: Chimertech Private Limited, Chennai, India.
  9. Tsehaye Asmelash: Department of Medical Microbiology and Immunology, College of Health Sciences, Mekelle University, Ethiopia.
PMID: 35686143 DOI: 10.1016/j.onehlt.2022.100390

Abstract

Purpose: The emergence of antimicrobial resistance is a major global health challenge and becoming an urgent priority for policymakers. There is a paucity of scientific studies presenting the multidrug resistance pattern from one health perspective in Ethiopia. Therefore, a systematic review and meta-analysis aimed to determine the pooled prevalence of multidrug resistance in bacteria from human, animal, food, and environmental sources.
Methods: In this systematic review and meta-analysis, an electronic search was made in PubMed & Google scholar using different keywords. The studies conducted in all areas of Ethiopia, published from 2015 to 2020 in peer-reviewed journals, English full-length papers were included. The meta-analysis was done on STATA version 14. The pooled prevalence of multidrug resistance for each bacterium was analysed using the random-effects model; Cochran Q statistics and the statistic was used to analyse heterogeneity and considered significant at p < 0.01.
Results: 81 studies were included in the systematic review and meta-analysis; 53 human studies, eight animal studies, and 16 environments/food studies. The meta-analysis included six species from gram-positive bacteria and 13 from gram-negative bacteria. 53% (95%CI: 42-64%), Coagulase negative 68%(95%CI:53-82), spp. 73%(95%CI:48-93%), 70% (95%CI:61-78%), spp. 71%(95%CI:54-87%), spp. 68% (54-80%), spp. 67% (48-83%) and spp. 65% (95%CI:48-81%) were the common multidrug-resistant species of bacteria from two or more sources.
Conclusion: In Ethiopia, the pooled prevalence of MDR is high in most bacterial species from humans, animals, food, and environmental sources. most members of the Enterobacteriaceae and are the standard MDR bacterial population involving all sources. Therefore, integrated policy and intervention measures should be implemented to reduce the emergence and spread of MDR bacteria for better animal and human health outcomes.

Keywords

Antimicrobial resistance CI, Confidence interval CoNS, Coagulase-negative Staphylococci ES, Estimate Ethiopia MDR, Multidrug resistance Multidrug resistance One health bacteria

References

  1. Stand Genomic Sci. 2010 Mar 30;2(2):212-9 [PMID: 21304704]
  2. Trends Biotechnol. 2000 Jan;18(1):14-6 [PMID: 10631774]
  3. BMC Complement Altern Med. 2012 Nov 09;12:214 [PMID: 23140177]
  4. Environ Sci Pollut Res Int. 2018 Apr;25(11):10538-10554 [PMID: 29288300]
  5. Int J Antimicrob Agents. 2009 Aug;34(2):103-10 [PMID: 19339161]
  6. Nucleic Acids Res. 2005 Oct 07;33(17):5691-702 [PMID: 16214803]
  7. Colloids Surf B Biointerfaces. 2013 Aug 1;108:255-9 [PMID: 23563291]
  8. J Nanobiotechnology. 2005 Jul 13;3:8 [PMID: 16014167]
  9. J Biomed Mater Res B Appl Biomater. 2012 Feb;100(2):409-15 [PMID: 22102276]
  10. J Appl Microbiol. 2000 Sep;89(3):397-403 [PMID: 11021571]
  11. Nanotechnology. 2005 Oct;16(10):2346-53 [PMID: 20818017]
  12. Brief Bioinform. 2019 Jul 19;20(4):1151-1159 [PMID: 29028869]
  13. Environ Microbiol. 2005 Mar;7(3):382-95 [PMID: 15683399]
  14. Afr Health Sci. 2018 Mar;18(1):32-40 [PMID: 29977255]
  15. Spectrochim Acta A Mol Biomol Spectrosc. 2013 Mar;104:265-70 [PMID: 23270884]
  16. Spectrochim Acta A Mol Biomol Spectrosc. 2015 May 5;142:339-43 [PMID: 25710891]
  17. J Pharm Bioallied Sci. 2016 Apr-Jun;8(2):83-91 [PMID: 27134458]
  18. BMC Complement Altern Med. 2013 Jul 26;13:192 [PMID: 23889893]
  19. BMC Bioinformatics. 2007 Jun 25;8:220 [PMID: 17592643]
  20. Indian J Pharmacol. 2008 Jun;40(3):107-10 [PMID: 20040936]
  21. Nanoscale Res Lett. 2014 May 12;9(1):229 [PMID: 24910577]
  22. Lancet Infect Dis. 2011 May;11(5):355-62 [PMID: 21478057]
  23. Nat Rev Microbiol. 2005 Jun;3(6):470-8 [PMID: 15931165]
  24. BMC Bioinformatics. 2008 Sep 19;9:386 [PMID: 18803844]
  25. IET Nanobiotechnol. 2014 Sep;8(3):172-8 [PMID: 25082226]
  26. Res Pharm Sci. 2014 Nov-Dec;9(6):385-406 [PMID: 26339255]
  27. Antonie Van Leeuwenhoek. 2005 Jan;87(1):3-9 [PMID: 15726285]
  28. Sci Rep. 2015 Sep 18;5:14179 [PMID: 26384169]
  29. Genome Biol. 2002;3(2):REVIEWS0003 [PMID: 11864374]
  30. Burns. 2000 Mar;26(2):131-8 [PMID: 10716355]
  31. Proc Natl Acad Sci U S A. 1987 Jan;84(1):274-8 [PMID: 3467354]
  32. Int J Mol Sci. 2012;13(8):9923-41 [PMID: 22949839]
  33. Antimicrob Agents Chemother. 2017 Jan 24;61(2): [PMID: 27919894]
  34. Genome Biol. 2010;11(8):R86 [PMID: 20738864]
  35. Microbiol Mol Biol Rev. 2008 Dec;72(4):557-78, Table of Contents [PMID: 19052320]
  36. Science. 2007 Feb 23;315(5815):1126-30 [PMID: 17272687]
  37. Environ Microbiol. 2004 Sep;6(9):938-47 [PMID: 15305919]
  38. Genome Biol. 2008 Oct 13;9(10):R151 [PMID: 18851752]
  39. Environ Health Perspect. 2013 Sep;121(9):993-1001 [PMID: 23838256]
  40. Genome Res. 2009 Nov;19(11):2144-53 [PMID: 19819906]
  41. Indian J Med Microbiol. 2008 Oct-Dec;26(4):322-6 [PMID: 18974483]
  42. Indian J Med Res. 2005 Feb;121(2):83-91 [PMID: 15756040]
  43. Appl Environ Microbiol. 2000 Jun;66(6):2541-7 [PMID: 10831436]
  44. Appl Environ Microbiol. 2006 Mar;72(3):1719-28 [PMID: 16517615]
  45. Colloids Surf B Biointerfaces. 2013 Feb 1;102:288-91 [PMID: 23006568]
  46. Chest. 2008 Aug;134(2):281-287 [PMID: 18682456]
  47. J Genet Eng Biotechnol. 2015 Dec;13(2):93-99 [PMID: 30647572]
  48. Clin Infect Dis. 2007 Apr 1;44(7):977-80 [PMID: 17342653]
  49. Int J Biol Macromol. 2016 Nov;92:63-69 [PMID: 27381582]
  50. BMC Bioinformatics. 2009 Dec 18;10:430 [PMID: 20021646]
  51. Crit Rev Biotechnol. 2008;28(4):277-84 [PMID: 19051106]
  52. Appl Environ Microbiol. 2002 Apr;68(4):2089-92 [PMID: 11916740]
  53. Sci Total Environ. 2017 Feb 1;579:1387-1398 [PMID: 27913024]
  54. Nucleic Acids Res. 2008 Apr;36(7):2230-9 [PMID: 18285365]
  55. IEEE Trans Nanobioscience. 2010 Dec;9(4):310-6 [PMID: 20876033]
  56. Genome Res. 2007 Mar;17(3):377-86 [PMID: 17255551]
  57. Trop Med Infect Dis. 2019 Jan 29;4(1): [PMID: 30700019]
  58. PLoS Biol. 2007 Mar;5(3):e75 [PMID: 17355175]
  59. J Appl Microbiol. 2018 Jun;124(6):1425-1440 [PMID: 29431875]
  60. Prog Biomater. 2017 May;6(1-2):57-66 [PMID: 28470622]
  61. J Bacteriol. 1998 Sep;180(18):4765-74 [PMID: 9733676]
  62. Int J Syst Evol Microbiol. 2001 May;51(Pt 3):797-814 [PMID: 11411701]
  63. Adv Colloid Interface Sci. 2009 Jan 30;145(1-2):83-96 [PMID: 18945421]
  64. Nanoscale Res Lett. 2016 Dec;11(1):520 [PMID: 27885623]
  65. Curr Top Med Chem. 2003;3(13):1512-35 [PMID: 14529524]
  66. Spectrochim Acta A Mol Biomol Spectrosc. 2015 Jan 5;134:310-5 [PMID: 25022503]
  67. Biotechnol Adv. 2009 Nov-Dec;27(6):924-937 [PMID: 19686832]
  68. J Adv Res. 2016 Jan;7(1):17-28 [PMID: 26843966]
  69. Clin Infect Dis. 2013 Sep;57(5):704-10 [PMID: 23723195]
  70. PLoS One. 2016 Nov 15;11(11):e0166519 [PMID: 27846254]
  71. PLoS One. 2008 Feb 27;3(2):e1548 [PMID: 18301734]
  72. Mar Drugs. 2019 Dec 19;18(1): [PMID: 31861527]
  73. Nat Methods. 2007 Jan;4(1):63-72 [PMID: 17179938]
  74. Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1501-6 [PMID: 20835879]
  75. Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6548-53 [PMID: 23576752]
  76. Nature. 2012 Aug 2;488(7409):86-90 [PMID: 22859206]
  77. Microbiol Rev. 1995 Mar;59(1):143-69 [PMID: 7535888]
  78. PLoS Genet. 2008 Oct;4(10):e1000223 [PMID: 18927628]
  79. Colloids Surf B Biointerfaces. 2010 Jun 1;77(2):257-62 [PMID: 20197229]
  80. Nanomedicine. 2010 Apr;6(2):257-62 [PMID: 19616126]
Journal Article Review
Article has an altmetric score of 3

Word Cloud

Created with Highcharts 10.0.0resistancestudiesmeta-analysisbacteriahealthsppEthiopiasystematicreviewsourcesMDRmultidrugpooledprevalencehumananimalincludedspeciesMultidrugemergenceoneperspectiveThereforefoodenvironmentalusing68%bacterialPurpose:antimicrobialmajorglobalchallengebecomingurgentprioritypolicymakerspaucityscientificpresentingpatternaimeddetermineMethods:electronicsearchmadePubMed&Googlescholardifferentkeywordsconductedareaspublished20152020peer-reviewedjournalsEnglishfull-lengthpapersdoneSTATAversion14bacteriumanalysedrandom-effectsmodelCochranQstatisticsstatisticusedanalyseheterogeneityconsideredsignificantp < 001Results:8153eight16environments/foodsixgram-positive13gram-negative53%95%CI:42-64%Coagulasenegative95%CI:53-8273%95%CI:48-93%70%95%CI:61-78%71%95%CI:54-87%54-80%67%48-83%65%95%CI:48-81%commonmultidrug-resistanttwoConclusion:highhumansanimalsmembersEnterobacteriaceaestandardpopulationinvolvingintegratedpolicyinterventionmeasuresimplementedreducespreadbetteroutcomesEthiopia:literature2015-2020AntimicrobialCIConfidenceintervalCoNSCoagulase-negativeStaphylococciESEstimateOne

Similar Articles

Cited By (8)